← Back to Clinical Trials
Recruiting NCT06555627

NCT06555627 Embracing Morning BReakfast and Activity for Classroom Engagement

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06555627
Status Recruiting
Phase
Sponsor University of Illinois at Chicago
Condition Child Development
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-02-03
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 11 Years
Study Type INTERVENTIONAL
Interventions
High Protein BreakfastMorning ExerciseHigh Carb Breakfast

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-02-03 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This experiment will test the effects of healthy breakfast and morning exercise on children's focus and classroom behavior. Food and exercise each influence child focus, but little is known about their effects on classroom behavior and less about their combined effects. For one week (Monday-Friday), 10 children will be randomly assigned to receive healthy breakfast and morning exercise, 10 assigned to only healthy breakfast, 10 to only exercise, and 10 to neither. After exercise and breakfast, study staff will assess how focused children are during class-time, ask them to complete puzzle-like tasks, and wear a helmet that measures brain blood flow

Eligibility Criteria

Inclusion Criteria: * 6-11 years old * Enrolled at the participating school Exclusion Criteria: * Younger than 5 years old * Older than 12 years old * Not enrolled in a participating school * Allergic to dairy or gluten

Contact & Investigator

Central Contact

Eduardo Bustamante

✉ ebusta2@uic.edu

📞 312 371 5620

Principal Investigator

Eduardo Bustamante

PRINCIPAL INVESTIGATOR

University of Illinois at Chicago

Frequently Asked Questions

Who can join the NCT06555627 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 11 Years, studying Child Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06555627 currently recruiting?

Yes, NCT06555627 is actively recruiting participants. Contact the research team at ebusta2@uic.edu for enrollment information.

Where is the NCT06555627 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT06555627 clinical trial?

NCT06555627 is sponsored by University of Illinois at Chicago. The principal investigator is Eduardo Bustamante at University of Illinois at Chicago. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology